EU agency authorizes Moderna’s COVID-19 vaccine

AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the desperate battle to tame the virus rampaging across the continent.

The approval recommendation by the European Medicines Agency’s human medicines committee — which must be rubber-stamped by the EU’s executive commission — comes amid high rates of infections in many EU countries and strong criticism of the slow pace of vaccinations across the region of some 450 million people.

“This vaccine provides us with another tool to overcome the current emergency,” said Emer Cooke, Executive Director of EMA.

“It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by WHO.”

European Commission President Ursula von der Leyen welcomed the move and added in a tweet: “Now we are working at full speed to approve it & make it available in the EU.”

The EMA has already approved a coronavirus vaccine made by American drugmaker Pfizer and Germany’s BioNTech.

Both vaccines require giving people two shots.

The EU has ordered 80 million doses of the Moderna vaccine with an option for a further 80 million.

The bloc also has committed to buying 300 million doses of the Pfizer-BioNTech vaccine.

Ahead of the meeting on the Moderna vaccine, the agency said in a tweet that its experts were “working hard to clarify all outstanding issues with the company.”

It did not elaborate on what those issues were.

Moderna also declined to comment.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.